4 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Total dose should ... Neutropenia 2-7% Alternative ... anti-IL6 mAb) #AntiIL6 ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
HIV-infected persons should ... PO TID (AII) Alternative ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
weekly (BIII) Alternative ... Note: Active TB should ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
mg PO daily Alternative ... empiric treatment should ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology